Authors


Nathan A. Pennell, MD, PhD

Latest:

Treating ALK-Positive Lung Cancer in the Weeks After the FDA Approval of Crizotinib

As physicians enter a new world of therapies for molecularly defined lung cancer, it will be critical for hospitals, drug companies, and insurance companies to work out the interplay of molecular testing and coverage for expensive therapies that are effective but only in smaller, defined groups of patients.



John Dickerson, PhD

Latest:

Acupuncture and Chiropractic Care: Utilization and Electronic Medical Record Capture

Most patients with chronic musculoskeletal pain use acupuncture or chiropractic care. A substantial percentage of this utilization, however, is not captured by the electronic medical record.





Bruce Alexander, PharmD

Latest:

Adding Glucose-Lowering Agents Delays Insulin Initiation and Prolongs Hyperglycemia

A review of national Veterans Health Administration data has identified how the number of glucose-lowering agents used prior to insulin initiation impacts glycemic control.


David A. Haggstrom, MD, MAS

Latest:

Cancer Care Disparities: Research Regarding Timeliness and Potential Coordination

Healthcare organizations and researchers should challenge themselves to provide increasingly timely data on cancer care disparities, until delays can be remedied as they happen.


Holly Korda, PhD, MA

Latest:

Value-Based Purchasing: The Evidence

A review of evidence about what works in 3 areas of value-based purchasing emphasized under healthcare reform: service delivery integration, payment, and value-based insurance design.




Martin Schiavenato, PhD, RN

Latest:

Applicability of the Omaha System in Acute Care Nursing for Information Interoperability in the Era of Accountable Care

Complex interventions from hospital settings mapped to Omaha System terms commonly used in community care; demonstrating its potential as a tool for interoperability across settings.


Tara F. Bishop, MD

Latest:

Association Between Physician Quality Improvement Incentives and Ambulatory Quality Measures

We found no consistent associations between physician incentives for quality improvement and 12 measures of ambulatory quality of care.



Ernest Shen, PhD

Latest:

Telehealth Transitional Care and 30-Day Readmission During the COVID-19 Pandemic

This study found that the dramatic shift from face-to-face posthospital transitional care to telehealth did not affect 30-day readmission or mortality during the COVID-19 pandemic.



Joan Shea, MBA, JD

Latest:

Study: Health Recovery Solutions Uses Tablets to Reduce Cardiac Readmissions

Pilot program implemented at Hackensack ACO that provides hospitals and ACOs an early warning system to manage their highest risk patients.


Cynthia J. Coffman, PhD

Latest:

Have Racial Disparities in Home Dialysis Utilization Changed Over Time?

Medicare prospective payment for dialysis modestly increased availability and use of home-based dialysis treatment but did not affect historic racial disparities in home dialysis.



Diane E. Meier, MD, FACP

Latest:

Achieving Value Through Palliative Care

Palliative care is an underutilized and powerful resource in the drive towards value. In the current article, we review published evidence and highlight how Medicare Advantage plans, accountable care organizations, and oncology practices can benefit from concurrent palliative care under value-based payments.


Anders Chen, MD

Latest:

Healthcare Reform With a Safety Net: Lessons From San Francisco

San Francisco is attempting to expand health insurance coverage and access to care while also supporting its healthcare safety net.


Brandon K. Koretz, MD

Latest:

Nurse Practitioner Comanagement for Patients in an Academic Geriatric Practice

Nurse practitioner comanagment improved quality of care for 5 chronic conditions in an academic geriatrics practice.



Bruce R. Schackman, PhD

Latest:

Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification

The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).



Catherine DesRoches, DrPH

Latest:

The Role of Health IT and Delivery System Reform in Facilitating Advanced Care Delivery

In 2012, electronic health record use and participation in accountable care organization or patient-centered medical home initiatives were associated with performing care processes expected to improve healthcare outcomes.


Eric P. Bargman, PhD

Latest:

Retail Clinic Versus Office Setting: Do Patients Choose Appropriate Providers?

Care episodes treated in retail clinics appeared to be less complex than those treated in office settings.


Christina M. Soerensen, MPH

Latest:

Episode of Care Analysis Reveals Sources of Variations in Costs

Costs of potentially avoidable complications have significantly more variation than costs of typical care in selected chronic and procedural episodes.


Mack Harris, BA

Latest:

Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCL

An economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).


Susan M. Shetterly, MS

Latest:

Improvements in Access and Care Through the Affordable Care Act

Affordable Care Act exchange enrollees in California and Colorado reported significant improvements in access to care and fewer barriers to receiving care due to costs.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo